Drug intelligence / Profile preview

acetylcholine + vasoactive intestinal polypeptide

Development stage
Preclinical
Modality
Peptides, Small Molecules, Recombinant Proteins and Enzymes
Administration
Intradermal, Iontophoresis, Intracavernosal, Intra-arterial, Intracerebral
01

Overview

Acetylcholine + vasoactive intestinal polypeptide is a combination of two endogenous neurotransmitters and vasodilators. Acetylcholine (ACh) is a classical neurotransmitter involved in cholinergic signaling, while vasoactive intestinal polypeptide (VIP) is a neuropeptide with potent vasodilatory and smooth muscle relaxant properties. When administered together, these agents have been shown to produce synergistic effects on vascular tone and smooth muscle relaxation in various tissues, including the skin, salivary glands, corpus cavernosum (erectile tissue), and cerebral vessels. The combination has been studied experimentally for its ability to induce strong vasodilation and modulate sensory responses such as pain or pruritus. Mechanistically, ACh acts primarily via muscarinic receptors to induce endothelium-dependent vasodilation through nitric oxide release; VIP acts via VPAC1R/VPAC2R receptors to activate adenylyl cyclase and increase cAMP levels in target cells[1][2][5][6][7]. The combination may be used experimentally to probe neurovascular function or as a research tool in studies of autonomic regulation.

Other names
acetylcholine + VIPACh + VIP
02

Targets

ADCYAP1R1 (Pituitary adenylate cyclase-activating polypeptide receptor PAC1)VIPR2 (Vasoactive intestinal polypeptide receptor 2)CHRM3 (M3)VIPR1 (Vasoactive intestinal peptide receptor 1)

Beyond the preview

Go deeper on acetylcholine + vasoactive intestinal polypeptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetylcholine + vasoactive intestinal polypeptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call